ESPERION THERAPEUTICS INC (ESPR) Stock Balance Sheet
NASDAQ:ESPR • US29664W1053
Current stock price
2.74 USD
+0.11 (+4.18%)
At close:
2.8 USD
+0.06 (+2.19%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 167.85M | 144.76M | 82.25M | 124.80M | 208.90M | |||
| Marketable Securities | N/A | N/A | 0.00 | 42.10M | 50.40M | |||
| Receivables | 140.19M | 80.14M | 48.49M | 33.70M | 22.90M | |||
| Inventories | 105.12M | 94.49M | 65.62M | 35.20M | 34.40M | |||
| Other Current Assets | 49.40M | 18.60M | 4.70M | 10.90M | 12.30M | |||
| Total Current Assets | 462.57M | 338.00M | 201.06M | 246.70M | 329.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.26M | 5.77M | 4.67M | 1.20M | 2.60M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 56.00K | 56.00K | 56.00K | 100.00K | 100.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 50.00M | |||
| Total Non-Current Assets | 3.32M | 5.82M | 4.73M | 1.20M | 52.60M | |||
| TOTAL ASSETS | 465.89M | 343.82M | 205.80M | 247.90M | 381.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 87.60M | 102.16M | 34.83M | N/A | N/A | |||
| Accrued Expenses | 113.67M | 83.90M | 64.28M | 41.00M | 38.80M | |||
| Accounts Payable | 65.07M | 51.65M | 31.72M | 23.00M | 17.60M | |||
| Other Current Liabilities | 34.48M | 8.52M | 25.40M | 28.30M | 17.00M | |||
| Total Current Liabilities | 300.81M | 246.23M | 156.22M | 92.30M | 73.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 457.65M | 483.74M | 501.55M | 259.90M | 258.30M | |||
| Other Non-Current Liabilities | 9.39M | 2.57M | 3.02M | 219.50M | 246.90M | |||
| Total Non-Current Liabilities | 467.04M | 486.31M | 504.57M | 479.40M | 505.10M | |||
| TOTAL LIABILITIES | 767.85M | 732.54M | 660.79M | 571.70M | 578.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.62B | -1.60B | -1.55B | -1.34B | -1.11B | |||
| Additional Paid In Capital | 1.38B | 1.27B | 1.15B | 1.07B | 964.40M | |||
| Common Shares | 245.00K | 196.00K | 118.00K | 100.00K | 100.00K | |||
| Treasury Stock | -55.00M | -55.00M | -55.00M | -55.00M | -55.00M | |||
| Other Shareholders' Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 245.22M | 195.85M | 118.21M | 74.60M | 60.90M | |||
| Tangible Book Value per Share | -1.23 | -1.99 | -3.85 | -4.34 | -3.23 | |||
| Total Shareholders' Equity | -301.96M | -388.72M | -454.99M | -323.80M | -196.90M | |||
| TOTAL LIABILITIES AND EQUITY | 465.89M | 343.82M | 205.80M | 247.90M | 381.60M | |||
| Statistics | ||||||||
| Debt/Equity | -1.52 | -1.24 | -1.10 | -0.80 | -1.31 | |||
| Current Ratio | 1.54 | 1.37 | 1.29 | 2.67 | 4.48 | |||
| Return On Assets (ROA) | -4.87% | -15.05% | -101.68% | -94.27% | -70.52% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital (ROIC) | 28.84% | 44.04% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21